Tiziana Life Sciences announced the appointment of Professor Roberto Pellicciari to the company's Scientific Advisory Board and as a consultant to the company. Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals Inc. Professor Pellicciari is presently Professor of Medicinal Chemistry at the University of Perugia in Italy and has held a number of prestigious scientific posts.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.99 USD | -1.00% | +7.73% | +76.79% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+76.79% | 102M | |
+44.43% | 56.65B | |
-6.90% | 39.44B | |
+39.27% | 39.03B | |
-11.17% | 26.86B | |
+13.46% | 26.75B | |
-21.31% | 19.03B | |
+0.52% | 12.28B | |
+26.16% | 12.26B | |
+27.44% | 12.04B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Appoints Roberto Pellicciari to the Scientific Advisory Board